Next Article in Journal
A Treat-and-Extend Regimen of Intravitreal Brolucizumab for Exudative Age-Related Macular Degeneration Refractory to Aflibercept: A 12-Month Result
Previous Article in Journal
Epigenetic Targets and Their Inhibitors in Thyroid Cancer Treatment
Previous Article in Special Issue
ABT-333 (Dasabuvir) Increases Action Potential Duration and Provokes Early Afterdepolarizations in Canine Left Ventricular Cells via Inhibition of IKr
 
 
Article

Article Versions Notes

Pharmaceuticals 2023, 16(4), 560; https://doi.org/10.3390/ph16040560
Action Date Notes Link
article xml file uploaded 7 April 2023 07:45 CEST Original file -
article xml uploaded. 7 April 2023 07:45 CEST Update https://www.mdpi.com/1424-8247/16/4/560/xml
article pdf uploaded. 7 April 2023 07:45 CEST Version of Record https://www.mdpi.com/1424-8247/16/4/560/pdf
article html file updated 7 April 2023 07:47 CEST Original file -
article html file updated 20 April 2023 20:58 CEST Update https://www.mdpi.com/1424-8247/16/4/560/html
Back to TopTop